MedStar Washington Hospital Center ( Site 0063) — Washington D.C., District of Columbia

Public research footprint of MedStar Washington Hospital Center ( Site 0063), compiled from the ClinicalTrials.gov public registry.

516

Registered studies

241

Active

101

Recruiting now

201

Completed

Stopped or withdrawn

Most-studied conditions

Lung Non-Small Cell Carcinoma · Stage IIIB Lung Cancer AJCC v8 · Stage IV Cutaneous Melanoma AJCC v6 and v7 · Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma

Recently updated registry entries

NCT05812807 — Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a… (Recruiting)
NCT06081894 — A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults… (Active Not Recruiting)
NCT06931340 — Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at MedStar Washington Hospital Center ( Site 0063)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.